Abstract
The role of hypoxic cell radiosensitisers has been extensively investigated for the past two decades. Efficacy in experimental models awaits validation in the clinic, but newer drugs currently entering clinical trial show considerable promise. Preferential hypoxic cell cytotoxicity by these electron-affinic agents was demonstrated about 10 years ago. Soon after the enhancement of this cytotoxity by hyperthermia was reported in cells in monolayer culture (Stratford and Adams 1977; Hall et al. 1977), multicellular tumour spheroids (Morgan and Bleehen 1981) and experimental tumours in vivo (Bleehen et al. 1977a; George et al. 1977). The purpose of this paper is briefly to review the topic of the interaction of heat with some hypoxic cell sensitisers. In addition we will also present some of our recent data on aspects of the pharmacology of this combination of treatment modalities. This updates reviews presented at the 2nd International Hyperthermia Symposium in Essen (Bleehen et al. 1978) and more recently by Adams et al. (1982).
We wish to thank our many colleagues who have contributed to this work, especially Ms. D.J.Honess. Part of this work was supported by a grant from the Cancer Research Campaign.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Adams GE, Stratford IJ, Rajaratnam S (1982) Interaction of the cytotoxic and sensitizing effects of electron-affinic drugs and hyperthermia. Natl Cancer Inst Monogr 61: 27–35
Bleehen NM (1983) Heat and drugs: current status of thermo-chemotherapy. In: Steel GG, Adams GE, Peckham MJ (eds) The biological basis of radiotherapy. Elsevier, Amsterdam, pp 321–332
Bleehen NM, Morgan JE (1982) Interaction between misonidazole, hyperthermia, and some cytotoxic drugs on multicellular tumour spheroids. In: Karcher KH et al. (eds) Progress in radio-oncology II, Raven, New York, pp 457–464
Bleehen NM, Honess DJ, Morgan JE (1977 a) Interaction of hyperthermia and the hypoxiccell sensitizer Ro 07-0582 on the EMT6 mouse tumour. Br J Cancer 35: 299–306
Bleehen NM, Honess DJ, Morgan JE (1977 b) Interaction of the hypoxic cell sensitizer Ro 07-0582 and hyperthermia on EMT6 tumour cells in vitro and in vivo. In: Radiobiological research and radiotherapy, vol 1. International Atomic Energy Agency, Vienna, pp 211–220
Bleehen NM, Honess DJ, Morgan JE (1978) The combined effects of hyperthermia and hypoxic cell sensitizers. In: Streffer C (ed) Cancer therapy by hyperthermia and radiation. Urban und Schwarzenberg, Munich, pp 62–71
Brown DM, Cohen MS, Sagerman RH, Gonzales-Mendez R, Hahn GM, Brown JM (1983) Influence of heat on the intracellular uptake and radiosensitisation of 2-nitroimidazole hypoxic cell sensitisers in vitro. Cancer Res 43: 3138–3142
Brown JM, Workman P (1980) Partition coefficient as a guide to the development of radiosensitizers which are less toxic that misonidazole. Radiat Res 82: 171–190
Coleman CN, Urtasun RC, Wasserman TD, Hancock S, Harris JW, Halsey J, Hirst VK (1984) Initial report of the phase 1 trial of the hypoxic cell radiosensitizer SR 2508. Int J Radiat Oncol Biol Phys 10: 1749–1753
Daly JM, Wang YM, Kapelanski D, Howard-Frazier O (1984) Systemic thermochemotherapy, toxicity and plasma pharmacokinetics of methotrexate and doxorubicin. J Surg Res 37: 343–347
Denekamp J (1978) Cytotoxicity and radiosensitization in mouse and man. Br J Radiol 57: 636–637
Dennis MF, Stratford MRL, Wardman P, Watts ME (1985) Cellular uptake of misonidazole analogues with acidic or basic functions. Int J Radiat Biol 47: 629–643
George KC, Hirst DG, McNally NJ (1977) Effect of hyperthermia on the cytotoxicity of the radiosensitizer Ro 07-0582 in a solid mouse tumour. Br J Cancer 35: 372–375
Gomer CJ, Johnson RJ (1979) Relationship between misonidazole toxicity and core temperature in C3H mice. Radiat Res 78: 329–333
Hall EJ, Astor M, Geard C, Biaglow J (1977) Cytotoxicity of Ro 07-0582; enhancement by hyperthermia and protection by cyteamine. Br J Cancer 35: 809–815
Honess DJ, Bleehen NM (1982) Sensitivity of normal mouse marrow and RIF-1 tumour to hyperthermia combined with cyclophosphamide or BCNU: a lack of therapeutic gain. Br J Cancer 46: 236–248
Honess DJ, Morgan JE, Bleehen NM (1978) The hyperthermic potentiation of the cytotoxic effect of misonidazole on the EMT6 mouse tumour: relevance of in vitro measurement of in vivo effect. Br J Cancer 37 [Suppl III]: 173–177
Honess DJ, Workman P, Morgan JE, Bleehen NM (1980) Effects of local hyperthermia on the pharmacokinetics of misonidazole in the anaesthetized mouse. Br J Cancer 41: 529–540
Honess DJ, Donaldson J, Workman P, Bleehen NM (1985) The effects of systemic hyperthermia on melphalan pharmacokinetics in mice. Br J Cancer 51: 77–84
Joiner MC, Vojnovic B (1982) Radiofrequency diathermy for uniform heating of mouse tumours. Br J Cancer 45 [Suppl V]: 71–76
Magin RL, Cysyk RL, Litterst KL (1980) Distribution of adriamycin in mice under conditions of local hyperthermia which improve systemic drug therapy. Cancer Treat Rep 64: 203–210
Malcolm SL, Lee A, Groves JK (1983) High-performance liquid Chromatographic analysis of the new hypoxic-cell radiosensitizer Ro 03-8799, in biological samples. J Chromatogr 273: 327–333
Mimnaugh EG, Waring RW, Sikic BI, Magin RL, Drew R, Litterst CL, Gram TE, Guarino AM (1978) Effects of WBH on the disposition and metabolism of adriamycin in rabbits. Cancer Res 38: 1420–1425
Morgan JE, Bleehen NM (1981) Interactions between misonidazole and hyperthermia in EMT6 spheroids. Br J Cancer 44: 810–818
Morgan JE, Bleehen NM (1982) Heat sensitivity of EMT6 multicellular tumour spheroids following misonidazole pre-treatment. Natl Cancer Inst Monogr 61: 153–155
Overgaard J (1979) Effects of local hyperthermia on the acute toxicity of misonidazole in mice. Br J Cancer 39: 96–98
Overgaard J (1980) Effects of misonidazole and hyperthermia on the radiosensitivity of a C3H mouse mammary carcinoma and its surrounding normal tissue. Br J Cancer 41: 10–21
Rajaratnam S, Adams GE, Stratford IT, Clarke C (1982) Enhancement of the cytotoxicity of radiosensitizers by modest hyperthermia: the electron-affinity relationship. Br J Cancer 46: 912–917
Rauth AM (1984) Pharmacology and toxicology of sensitizers: mechanism studies. Int J Radiat Oncol Biol Phys 10: 1293–1300
Roberts JT, Bleehen NM, Walton MI, Workman P (1986) A clinical phase I toxicity study of Ro 03-8799: plasma, urine, tumour and normal brain pharmacokinetics. Br J Radiol 59: 107–116
Sathiaseelan V, Har-Kedar I, Howard GCW, Bleehen NM (1983) A microcomputer-controlled microwave hyperthermia system. J Microcomp Appl 6: 261–277
Smith JM, Robinson S, Pearcy M (1952) Renal responses to exercise, heat and dehydration. J Appl Physiol 4: 659–665
Stratford IJ, Adams GE (1977) Effect of hyperthermia on differential cytotoxicity of a hypoxic cell radiosensitizer, Ro 07-0582, on mammalian cells in vitro. Br J Cancer 35: 307–313
Stratford IJ, Watts ME, Adams GE (1978) The effect of hyperthermia on the differential cytotoxicity of some electron-affinic hypoxic cell radiosensitizers on mammalian cells in vitro. Streffer C (ed) Cancer therapy by hyperthermia and radiation. Urban and Schwarzenberg, Munich, pp 267–270
Sutherland RM, Bareham BJ, Reich KA (1980) Cytotoxicity of hypoxic cell sensitizers in multicell spheroids. Cancer Clin Trials 3: 73–83
Walton MI, Bleehen NM, Workman P (1987 a) The effects of whole body hyperthermia on the pharmacokinetics and toxicity of the basic 2-nitroimidazole radiosensitizer Ro 03-8799 in mice. Br J Cancer 55: 469–476
Walton MI, Bleehen NM, Workman P (1987 b) Heat stimmulated nitroreductive bioactivation of the 2-introimidazole benzoidazole in vitro. Biochem Pharmacol 36: 2627–2632
Watts ME, Jones NR (1985) The effect of extracellular pH on radiosensitization by misonidazole and acidic and basic analogues. Int J Radiat Biol 47,6: 645–653
White RAS, Workman P (1980) Pharmacokinetic and tumour penetration properties of the hypoxic-cell radiosensitizer desmethylmisonidazole (Ro 05-9963) in dogs. Br J Cancer 41: 268–276
Williams MV, Denekamp J, Minchinton AL, Stratford MRL (1982) In vivo assessment of basic 2-nitroimidazole radiosensitizers. Br J Cancer 46: 127–137
Wondergem J, Haveman J, van der Schueren E, van der Hoeven H, Breur K (1982) Effect of hyperthermia and misonidazole on the radiosensitivity of a transplantable murine tumour: influence of factors modifying the fraction of hypoxic cells. Int J Radiat Oncol Biol Phys 8: 1323–1331
Workman P (1979) Effects of pretreatment with phenobarbitone and phenytoin on the pharmacokinetics and toxicity of misonidazole in mice. Br J Cancer 40: 335–353
Workman P (1980) Dose-dependence and related studies on the pharmacokinetics of misonidazole in mice. Cancer Chemother Pharmacol 5: 27–37
Workman P, Brown JM (1981) Structure-pharmacokinetic relationships for misonidazole analogues in mice. Cancer Chemother Pharmacol 6: 39–49
Workman P, Little CJ, Marten TR, Dale AD, Ruane RJ, Flockhart IR, Bleehen NM (1978) Estimation of the hypoxic cell sensitizer misonidazole and its 0-demethylated metabolite in biological materials by reverse-phase high-performance liquid chromatography. J Chromatogr 145: 507–512
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1988 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Bleehen, N.M., Walton, M.I., Workman, P. (1988). Interactions of Hyperthermia with Hypoxic Cell Sensitisers. In: Hinkelbein, W., Bruggmoser, G., Engelhardt, R., Wannenmacher, M. (eds) Preclinical Hyperthermia. Recent Results in Cancer Research, vol 109. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-83263-5_16
Download citation
DOI: https://doi.org/10.1007/978-3-642-83263-5_16
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-83265-9
Online ISBN: 978-3-642-83263-5
eBook Packages: Springer Book Archive